DBV Technologies joins the CAC Mid 60 and SBF 120 indices

DBV Technologies, a late-stage biopharmaceutical company, recently announced its inclusion in the CAC Mid 60 and SBF 120 indices, following the annual review of the Euronext Paris indices. These changes took effect on March 23, 2026, after the close of financial markets. This decision marks a significant milestone for DBV, reflecting recognition of the company's continued progress.

DBV Technologies CEO Daniel Tassé commented on this inclusion, emphasizing that it will increase the company's visibility within the investment community in France and Europe. The CAC Mid 60 and SBF 120 are important benchmarks for investors, comprising 60 and 120 of the most active companies in France, respectively.